Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $195.00 | 10 | 93.7% |
| Education | $13.11 | 1 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $109.16 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $29.47 | 2 | $0 (2018) |
| Alkermes, Inc. | $23.20 | 1 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $18.21 | 1 | $0 (2022) |
| Gilead Sciences Inc | $14.96 | 1 | $0 (2017) |
| Colgate Oral Pharmaceuticals, Inc. | $13.11 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.51 | 1 | Janssen Pharmaceuticals, Inc ($28.51) |
| 2023 | $42.68 | 2 | Janssen Pharmaceuticals, Inc ($42.68) |
| 2022 | $56.18 | 3 | Janssen Pharmaceuticals, Inc ($37.97) |
| 2021 | $13.11 | 1 | Colgate Oral Pharmaceuticals, Inc. ($13.11) |
| 2018 | $52.67 | 3 | Neurocrine Biosciences, Inc. ($29.47) |
| 2017 | $14.96 | 1 | Gilead Sciences Inc ($14.96) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Neuroscience | ||||||
| 10/10/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Neuroscience | ||||||
| 05/10/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Neuroscience | ||||||
| 11/17/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/19/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Neuroscience | ||||||
| 06/22/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Neuroscience | ||||||
| 04/23/2021 | Colgate Oral Pharmaceuticals, Inc. | — | Education | In-kind items and services | $13.11 | General |
| 06/22/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: NEUROLOGY | ||||||
| 03/30/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: NEUROLOGY | ||||||
| 02/20/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: CNS | ||||||
| 09/19/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $14.96 | General |
About Dr. Sonja Stiff, D.M.D
Dr. Sonja Stiff, D.M.D is a Dentist healthcare provider based in Pearl, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891720454.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonja Stiff, D.M.D has received a total of $208.11 in payments from pharmaceutical and medical device companies, with $28.51 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($195.00).
Practice Information
- Specialty Dentist
- Location Pearl, MS
- Active Since 07/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 122300000X
- Entity Type Individual
- NPI Number 1891720454
Products in Payments
- INVEGA SUSTENNA (Drug) $109.16
- INGREZZA (Drug) $29.47
- Vivitrol 380 mg (Drug) $23.20
- HETLIOZ (Drug) $18.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.